LF

본문 바로가기

Investor Relations

We are committed to increasing shareholder value through strengthening of corporate values and proactively promoting IR activities.

Income Statement

Consolidated Balance Sheet
ITEM	20th FY 1H	19th	18th	17th	16th
Noncurrent assets	18,971	16,690	15,062	12,383	11,968
Current assets	11,977	12,459	12,494	13,458	13,443
Total Assets	30,948	29,150	27,556	25,840	25,411
Controlling interest	15,943	15,717	15,281	14,689	13,349
Issued capital	1,462	1,462	1,462	1,462	1,462
Consolidated capital surplus	2,136	2,136	2,136	2,137	2,131
Consolidated capital adjustment	(388)	(358)	(186)	(186)	(160)
Consolidated retained earnings	12,706	12,430	11,886	11,294	9,948
Consolidated accumulated other comprehensive income	27	48	(16)	(19)	(32)
Non-controlling interest	2,049	2,011	1,855	1,880	1,635
Total stockholders’ equity	17,992	17,728	17,136	16,568	14,984
Noncurrent liabilities	5,562	6,471	2,258	1,844	4,296
Current liabilities	7,395	4,951	8,162	7,428	6,132
Total liabilities	12,956	11,422	10,421	9,272	10,428
Total stockholders’ equity and liabilities	30,948	29,150	27,556	25,840	25,411

Consolidated Income Statement
ITEM	20th FY 1H	19th FY 1H	19th	18th	17th	16th
Revenue	8,860	9,158	19,563	19,007	19,685	17,931
Costs of goods sold	(3,709)	(3,973)	(8,427)	(8,063)	(7,982)	(6,950)
Gross profit	5,151	5,185	11,135	10,944	11,704	10,981
Selling and administrative expenses	(4,408)	(4,722)	(9,874)	(10,370)	9,852	9,392
Operating profit	744	463	1,261	574	1,852	1,589
Finance income	68	75	143	166	109	63
Finance costs	(126)	(160)	(303)	(225)	(104)	(127)
Other non-operating income and expense	85	100	219	243	574	736
Other non-operating expenses	(114)	(49)	(231)	(159)	(234)	(310)
Investment Income Using the Equity Method	58	31	62	29	41	42
Income before income tax expense	715	459	1,151	628	2,238	1,994
Income tax expense	(176)	(59)	(245)	172	(465)	(632)
Consolidated net income	539	400	906	801	1,773	1,362

Summary of Financial Statement

Separate Balance Sheet
ITEM	20th FY 1H	19th	18th	17th	16th
Noncurrent assets	14,164	13,745	12,453	12,237	10,847
Current assets	6,106	6,042	7,095	7,500	7,537
Total Assets	20,270	19,787	19,548	19,737	18,384
Issued capital	1,462	1,462	1,462	1,462	1,462
Capital surplus	2,132	2,132	2,132	2,132	2,132
Elements of other stockholder's equity	(318)	(295)	(141)	(139)	(134)
retained earnings	13,158	12,883	12,332	11,763	10,452
Other Comprehensive income/loss	6	26	(39)	(40)	(61)
accumulated amount	16,441	16,208	15,746	15,178	13,851
Noncurrent liabilities	1,525	2,148	1,244	1,268	2,428
Current liabilities	2,304	1,432	2,558	3,292	2,106
Total liabilities	3,830	3,580	3,802	4,559	4,534
Total stockholders’ equity and liabilities	20,270	19,787	19,548	19,737	18,384

Separate Income Statement
ITEM	20th FY 1H	19th FY 1H	19th	18th	17th	16th
Revenue	5,669	6,147	12,053	12,726	12,719	11,455
Costs of goods sold	(2,235)	(2,444)	(4,820)	(4,908)	(4,921)	(4,440)
Gross profit	3,434	3,703	7,233	7,818	7,798	7,015
Selling and administrative expenses	(3,006)	(3,386)	(6,575)	(7,266)	(7,040)	(6,234)
Operating profit	429	317	658	552	758	780
Finance income	53	60	117	129	107	69
Finance costs	(61)	(71)	(155)	(136)	(63)	(71)
Other non-operating income and expense	54	73	162	169	499	709
Other non-operating expenses	(68)	(34)	(111)	(90)	(185)	(83)
Using the Equity Method	167	61	213	65	595	388
Income before income tax expense	575	407	884	689	1,709	1,792
Income tax expense	(106)	(60)	(109)	134	(151)	(363)
Consolidated net income	469	347	776	823	1,558	1,430